Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2026

Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Overview

• Cardiovascular Monitoring And Diagnostic Devices And Equipment market size has reached to $4.12 billion in 2025 • Expected to grow to $5.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.3% • Growth Driver: Elevated Prevalence Of Obesity And Diabetes Catalysts For Growth In The Cardiovascular Monitoring And Diagnostic Devices Market • Market Trend: Boston Scientific Unveils Innovative Lux-Dx Ii+ Icm System For Enhanced Cardiovascular Monitoring And Diagnosis • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Cardiovascular Monitoring And Diagnostic Devices And Equipment Market?

Cardiovascular monitoring and diagnostic devices and equipment are used for the diagnosis, monitoring, and treatment of cardiovascular diseases. The main product types of cardiovascular monitoring and diagnostic devices and equipment are cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and Holter monitoring systems. ECG monitoring equipment is an electronic device that is used to record the electrical activity of the heart. The various types involved are heart disease and coronary heart disease. The various end-users involved are hospitals or physician clinics (continuous glucose monitors), home or emergency, and research and development (clinical trials, universities, CRO).

What Is The Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Growth Forecast?

The cardiovascular monitoring and diagnostic devices and equipment market size is expected to see steady growth in the next few years. It will grow to $5.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring, rising adoption of ai-assisted diagnostics, expansion of telecardiology services, growing investments in digital healthcare infrastructure, continuous innovation in non-invasive monitoring technologies. Major trends in the forecast period include increasing adoption of remote cardiac monitoring systems, rising use of wearable ecg devices, growing integration of cloud-based data management platforms, expansion of continuous and wireless monitoring solutions, enhanced focus on early disease detection.

Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Segmentation

1) By Product Type: Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems 2) By Disease Indication: Heart Disease, Coronary Heart Disease 3) By End-Use: Hospitals Or Physician Clinic (Continuous Glucose Monitors), Home Or Emergency, Research and Development (Clinical Trials, Universities, CRO) Subsegments: 1) By Cardiopulmonary Stress Testing Systems: Treadmill Stress Testing Systems, Ergometer Stress Testing Systems, Respiratory Gas Exchange Systems, Other Cardiopulmonary Stress Testing Systems 2) By ECG Data Management Systems: Cloud-Based ECG Data Management Systems, On-Premise ECG Data Management Systems, ECG Software For Data Analysis, Other ECG Data Management Systems 3) By ECG Monitoring Equipment: Continuous ECG Monitors, Wireless ECG Monitors, Handheld ECG Monitors, Other ECG Monitoring Equipment 4) By ECG Stress Testing Systems: Treadmill ECG Stress Testing Systems, Cycle Ergometer ECG Stress Testing Systems, Automated ECG Stress Testing Systems, Other ECG Stress Testing Systems 5) By Event Monitoring Systems: Mobile Event Monitors, Wireless Event Monitors, Holter Or Event Monitor Hybrid Systems, Other Event Monitoring Systems 6) By Holter Monitoring Systems: 24-Hour Holter Monitors, 48-Hour Holter Monitors, 7-Day Holter Monitors, Other Holter Monitoring Systems

What Is The Driver Of The Cardiovascular Monitoring And Diagnostic Devices And Equipment Market?

The cardiovascular monitoring and diagnostic devices and equipment market is being driven by an increasing number of people suffering from obesity and diabetes. Risk factors including high blood pressure and high cholesterol are associated with obesity and diabetes leads to cardiovascular diseases. For instance, as per a study conducted by the American Heart Association (AMA), by 2030, 22.2 million CVD is expected to grow. According to another study conducted by AMA in the U.S., 26 million people have been diagnosed with diabetes, and above 9 million further, have the condition but it hasn't yet been diagnosed.

Key Players In The Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market

Major companies operating in the cardiovascular monitoring and diagnostic devices and equipment market are Medtronic PLC, Boston Scientific Corporation, GE Healthcare, Philips Healthcare, Siemens Healthcare, St. Jude Medical Inc., Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Sorin Group, Welch Allyn Inc., LivaNova PLC, Spacelabs Healthcare, Opto Circuits India Ltd., BPL Health Management Solutions, OSI Systems Inc., Schiller AG, Abbott Cardiovascular, Aerotel Medical Systems Ltd., Dräger Medical AG & Co. KGaA, Biotronik Inc., Koninklijke Philips N.V., Endotronix Inc., Smartcardia, Ivy Biomedical Systems Inc., Cardio Diagnostics Holdings Inc., ECG Excellence BV, Aktiia SA, HD Medical, HeartFlow Inc., VPG Medical, BioTelemetry Inc., Preventice Solutions, Mortara Instrument Inc., Getemed Medizin-Und Informationstechnik AG, LifeWatch Technologies Ltd., QRS Diagnostic

Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Trends and Insights

Major companies operating in the cardiovascular monitoring and diagnostic devices and equipment market are developing innovative products such as LUX-Dx II+ to better serve patients. The LUX-Dx II+ insertable cardiac monitor (ICM) system is a next-generation ICM system that provides physicians with a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats. For instance, in October 2023, Boston Scientific, a US-based manufacturing company launched LUX-Dx II+. The LUX-Dx II+ insertable cardiac monitor (ICM) system provides physicians with a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats. The system is designed with dual-stage algorithms, clear S-ECG signal quality, remote programming, wireless connectivity, a patient app, and a small size.

What Are Latest Mergers And Acquisitions In The Cardiovascular Monitoring And Diagnostic Devices And Equipment Market?

In May 2024, WearLinq Inc., a US-based provider of digital healthcare solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This acquisition strengthens WearLinq’s position in the ambulatory cardiac monitoring market by expanding nationwide access to its FDA-cleared eWave 6-lead ECG monitor and integrating AMI’s clinical diagnostic expertise. It further enhances the company’s cardiac-diagnostics capabilities by combining advanced wearable monitoring technology with established Medicare-certified diagnostic services. AMI Cardiac Monitoring LLC is a US-based privately held Independent Diagnostic Testing company offering cardiovascular monitoring and diagnostic equipment.

Regional Outlook

North America was the largest region in global cardiovascular monitoring and diagnostic devices and equipment market in 2025. Western Europe was the second-largest region in cardiovascular monitoring and diagnostic devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Cardiovascular Monitoring And Diagnostic Devices And Equipment Market?

The cardiovascular monitoring and diagnostic devices and equipment market consist of sales of cardiopulmonary stress testing systems, electrocardiogram (ECG) data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and holter monitoring systems that are used for diagnosis and treatment of cardio diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.